Moreover, SNHG14 promotes breast cancer tumorigenesis via regulating Nfr2 pathway depending on PABPC1. In summary, our study revealed that lncRNA SNHG14 promotes breast cancer progression and chemo‐resistance to trastuzumab treatment both in vitro and in vivo. Here, PABPC1 is linked to breast cancer.